Remibrutinib for peanut, milk, or egg allergies
Treatments studied
Part of Immune system & allergy clinical trials.
This study tests an investigational drug called remibrutinib to see if it can reduce allergic reactions to peanuts, milk, or eggs. It is for people aged 12 to 65 who have been diagnosed with a food allergy and are willing to participate in food challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 65 years old.
- You must have a confirmed allergy to peanuts, milk, or eggs, shown by a blood test and a skin prick test.
- You must have a positive food challenge at the start of the study, meaning you react to a small amount of the allergen.
- You must be willing to avoid the allergen (peanut, milk, or egg) and any other foods you are allergic to during the study.
- You must not have used remibrutinib or other BTK inhibitors before.
- You must be able to attend study visits and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This trial tests a new medication (remibrutinib) versus a placebo to see if it helps adults with generalized myasthenia gravis. You may qualify if your symptoms affect multiple parts of your body and you haven't had certain recent treatments.
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
This trial tests an experimental drug called Remibrutinib for people with chronic hives (urticaria) that are not well controlled with standard antihistamines. The goal is to see if the drug reduces symptoms like itching and wheals.
This study tests an investigational medicine (remibrutinib) for people with severe itching that has no known cause. It may help reduce the itch when moisturizers haven't worked.
Hear when a new Peanut Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.